Undetermined Music Artists

Sharing Artistopia
 
Music Is Life @ Artistopia.com

Independent Music Artist:   Sign In  |  Register

Home Music Indie News Discussion Resources Shop Saturday, May 26, 2012
  
 
 
  
 

Malaria

Music Home >>  Music Genres  >> Undetermined Music
 
  
 

< < < < <
> > > > >
More Info on Malaria Similar Undetermined Music Search Artistopia

Biography

Infobox disease| Name = Malaria| ICD10 = ICD10|B|50||b|50| ICD9 = ICD9|084| Image = Plasmodium.jpg| Caption = Ring-forms and gametocyte s of Plasmodium falciparum in human blood.| DiseasesDB = 7728| MedlinePlus = 000621| OMIM = 248310| eMedicineSubj = med| eMedicineTopic = 1385| eMedicine_mult = eMedicine2|emerg|305 eMedicine2|ped|1357| MeshName = Malaria| MeshNumber = C03.752.250.552 | Malaria is a Mosquito-borne disease|mosquito-borne infectious disease of humans and other animals caused by eukaryotic protists (a type of microorganism) of the genus Plasmodium . The protists act as parasites within red blood cell s, causing symptoms that typically include fever and headache , in severe cases progressing to coma or death . The disease is widespread in Tropics|tropical and subtropical regions in a broad band around the equator, including much of Sub-Saharan Africa , Asia , and the Americas .


Five species of Plasmodium can infect and be transmitted by humans. Severe disease is largely caused by Plasmodium falciparum|P.& nbsp;falciparum while the disease caused by Plasmodium vivax|P.& nbsp;vivax , Plasmodium ovale|P.& nbsp;ovale , and Plasmodium malariae|P.& nbsp;malariae is generally a milder form that is rarely fatal. The zoonosis|zoonotic species Plasmodium knowlesi|P.& nbsp;knowlesi , prevalent in Southeast Asia, causes malaria in macaques but can also cause severe infections in humans. Malaria is prevalent in tropical regions because of the significant amounts of rainfall, consistently high temperatures and high humidity, along with stagnant waters in which mosquito larvae readily mature, provide them with the environment they need for continuous breeding. Disease transmission can be reduced by preventing mosquito bites by distribution of mosquito net s and insect repellent s, or with mosquito-control measures such as spraying insecticide s and draining standing water.


The WHO has estimated that malaria annually causes over 200 million cases of fever; in 2010, around 655,000 people died from the disease, most of whom were children under the age of five. The actual number of deaths may be significantly higher, as precise statistics are unavailable in many rural areas, and many cases are undocumented. P.& nbsp;falciparum —responsible for the most severe form of malaria—causes the vast majority of deaths associated with the disease. Malaria is commonly associated with poverty, and can indeed be a cause of poverty and a major hindrance to economic development .


Despite a clear need, no vaccine offering a high level of protection currently exists. Efforts to develop one are ongoing. A number of medications are available to prevent malaria in travelers to malaria- Endemic (epidemiology)|endemic countries ( malaria prophylaxis|prophylaxis ). A variety of antimalarial medication s are available. Severe malaria is treated with Intravenous therapy|intravenous or Intramuscular injection|intramuscular quinine or, since the mid-2000s, the artemisinin derivative artesunate , which is superior to quinine in both children and adults. Drug resistance|Resistance has developed to several antimalarial drugs, most notably chloroquine and artemisinin.

Signs and symptoms




Symptoms of malaria include fever , shivering , arthralgia (joint pain), vomiting , hemolytic anemia , jaundice , hemoglobinuria , Retinopathy|retinal damage , and convulsion s. The classic symptom of malaria is cyclical occurrence of sudden coldness followed by Rigor (medicine)|rigor and then fever and sweating lasting about two hours or more, occurring every two days in P.& nbsp;vivax and P.& nbsp;ovale infections, and every three days for P.& nbsp;malariae . P.& nbsp;falciparum infection can cause recurrent fever every 36–48 hours or a less pronounced and almost continuous fever. For reasons that are poorly understood, but that may be related to high intracranial pressure , children with malaria frequently exhibit abnormal posturing , a sign indicating severe brain damage. Cerebral malaria is associated with retinal whitening, which may be a useful clinical sign in distinguishing malaria from other causes of fever.

Severe malaria is almost exclusively caused by P.& nbsp;falciparum , and usually arises 6–14 days after infection. Consequences of severe malaria include coma and death if untreated—young children and pregnant women are especially vulnerable. Splenomegaly (enlarged spleen), severe headache , cerebral ischemia , hepatomegaly (enlarged liver), hypoglycemia , and hemoglobinuria with renal failure may occur. Renal failure is a feature of blackwater fever , where hemoglobin from lysis|lysed red blood cells leaks into the urine.

Cause



Malaria parasite s are members of the genus Plasmodium (phylum Apicomplexa ). In humans malaria is caused by Plasmodium falciparum|P.& nbsp;falciparum , Plasmodium malariae|P.& nbsp;malariae , Plasmodium ovale|P.& nbsp;ovale , Plasmodium vivax|P.& nbsp;vivax and Plasmodium knowlesi|P.& nbsp;knowlesi . While P.& nbsp;vivax is responsible for the largest number of malaria infections worldwide, infections by P.& nbsp;falciparum account for the vast majority of deaths from malaria. Parasitic Plasmodium species also infect birds, reptiles, monkeys, chimpanzees and rodents. There have been documented human infections with several simian species of malaria; however, with the exception of P.& nbsp;knowlesi —a zoonosis|zoonotic species that causes malaria in macaques —these are mostly of limited public health importance.

Life cycle


The host (biology)|definitive hosts for malaria parasites are female mosquitoes of the Anopheles genus, which act as transmission Vector (epidemiology)|vectors to humans and other vertebrates, the secondary hosts. Young mosquitoes first ingest the malaria parasite by feeding on an infected vertebrate carrier and the infected Anopheles mosquitoes eventually carry Plasmodium sporozoite s in their salivary gland s. A mosquito becomes infected when it takes a blood meal from an infected vertebrate. Once ingested, the parasite gametocytes taken up in the blood will further differentiate into male or female gametes and then fuse in the mosquito's gut. This produces an ookinete that penetrates the gut lining and produces an oocyst in the gut wall. When the oocyst ruptures, it releases sporozoites that migrate through the mosquito's body to the salivary glands, where they are then ready to infect a new human host. The sporozoites are injected into the skin, alongside saliva, when the mosquito takes a subsequent blood meal. This type of transmission is occasionally referred to as anterior station transfer.

Only female mosquitoes feed on blood; male mosquitoes feed on plant nectar, and thus do not transmit the disease. The females of the Anopheles genus of mosquito prefer to feed at night. They usually start searching for a meal at dusk, and will continue throughout the night until taking a meal. Malaria parasites can also be transmitted by blood transfusion s, although this is rare.

Recurrent malaria


Malaria recurs after treatment for three reasons. Recrudescence occurs when parasites are not cleared by treatment, whereas reinfection indicates complete clearance with new infection established from a separate infective mosquito bite; both can occur with any malaria parasite species. Relapse is specific to P.& nbsp;vivax and P.& nbsp;ovale and involves re-emergence of blood-stage parasites from latent parasites (hypnozoites) in the liver. Describing a case of malaria as cured by observing the disappearance of parasites from the bloodstream can, therefore, be deceptive. The longest incubation period reported for a P.& nbsp;vivax infection is thirty years. Approximately one in five of P.& nbsp;vivax malaria cases in temperate areas involve overwintering by hypnozoites, with relapses beginning the year after the mosquito bite.

Pathogenesis


further2| Plasmodium falciparum biology| Plasmodium falciparum biology Malaria develops via two phases: an exoerythrocytic and an erythrocytic phase. The exoerythrocytic phase involves infection of the hepatic system, or liver , whereas the erythrocytic phase involves infection of the red blood cell|erythrocytes , or red blood cells. When an infected mosquito pierces a person's skin to take a blood meal, sporozoite s in the mosquito's saliva enter the bloodstream and migrate to the liver where they infect hepatocyte s, multiplying asexually and asymptomatically for a period of 8–30 days. After a potential dormant period in the liver, these organisms cellular differentiation|differentiate to yield thousands of merozoite s, which, following rupture of their host cells, escape into the blood and infect red blood cells to begin the erythrocytic stage of the life cycle. The parasite escapes from the liver undetected by wrapping itself in the cell membrane of the infected host liver cell.

Within the red blood cells, the parasites multiply further, again asexually, periodically breaking out of their hosts to invade fresh red blood cells. Several such amplification cycles occur. Thus, classical descriptions of waves of fever arise from simultaneous waves of merozoites escaping and infecting red blood cells.

Some P.& nbsp;vivax sporozoites do not immediately develop into exoerythrocytic-phase merozoites, but instead produce hypnozoites that remain dormant for periods ranging from several months (6–12 months is typical) to as long as three years. After a period of dormancy, they reactivate and produce merozoites. Hypnozoites are responsible for long incubation and late relapses in P.& nbsp;vivax infections, although their existence in P.& nbsp;ovale is uncertain.

The parasite is relatively protected from attack by the body's immune system because for most of its human life cycle it resides within the liver and blood cells and is relatively invisible to immune surveillance. However, circulating infected blood cells are destroyed in the spleen . To avoid this fate, the P.& nbsp;falciparum parasite displays adhesive protein s on the surface of the infected blood cells, causing the blood cells to stick to the walls of small blood vessels, thereby sequestering the parasite from passage through the general circulation and the spleen. This "stickiness" is the main factor giving rise to hemorrhage|hemorrhagic complications of malaria. High endothelial venules (the smallest branches of the circulatory system) can be blocked by the attachment of masses of these infected red blood cells. The blockage of these vessels causes symptoms such as in placental and cerebral malaria. In cerebral malaria the sequestrated red blood cells can breach the blood–brain barrier possibly leading to coma.

Although the red blood cell surface adhesive proteins (called PfEMP1 , for P.& nbsp;falciparum erythrocyte membrane protein 1) are exposed to the immune system, they do not serve as good immune targets, because of their extreme diversity; there are at least 60 variations of the protein within a single parasite and even more variants within whole parasite populations. The parasite switches between a broad repertoire of PfEMP1 surface proteins, thus staying one step ahead of the pursuing immune system.

Some merozoites turn into male and female gametocyte s. If a mosquito pierces the skin of an infected person, it potentially picks up gametocytes within the blood. Fertilization and sexual recombination of the parasite occurs in the mosquito's gut. (Because sexual reproduction of the parasite defines the definitive host , the mosquito is the definitive host, whereas humans are the intermediate host .) New sporozoites develop and travel to the mosquito's salivary gland, completing the cycle. Pregnant women are especially attractive to the mosquitoes, and pregnancy-associated malaria|malaria in pregnant women is an important cause of stillbirth s, infant mortality and low birth weight , particularly in P.& nbsp;falciparum infection, but also in other species infection, such as P.& nbsp;vivax .

Genetic resistance


Main|Genetic resistance to malariaMalaria is thought to have been the greatest selection|selective pressure on the human genome in recent history. This is due to the high levels of death|mortality and morbidity caused by malaria, especially the Plasmodium falciparum|P.& nbsp;falciparum species. A number of diseases may provide some resistance to it including sickle cell disease , thalassaemias , glucose-6-phosphate dehydrogenase deficiency as well as the presence of Duffy antigen s on the subject's red blood cells.

The impact of sickle cell anemia on malaria immunity is of particular interest. Sickle cell anemia causes a defect to the hemoglobin molecule in the blood. Instead of retaining the biconcave shape of a normal red blood cell, the modified hemoglobin S molecule causes the cell to sickle or distort into a curved shape. Due to the sickle shape, the molecule is not as effective in taking or releasing oxygen, and therefore malaria parasites cannot complete their life cycle in the cell. Individuals who are homozygous for sickle cell anemia seldom survive this defect, while those who are heterozygous experience immunity to the disease. Although the potential risk of death for those with the homozygous condition seems to be unfavorable to population survival, the trait is preserved because of the heterozygote advantage|benefits provided by the heterozygous form.

Malarial hepatopathy


Hepatic dysfunction as a result of malaria is rare and is usually a result of a coexisting liver condition such as viral hepatitis and chronic liver disease . To be clear, the term "malarial hepatitis" is sometimes used to describe liver compromise in severe malaria; however, actual inflammation of the liver parenchyma is rarely seen. While traditionally considered a rare occurrence, malarial hepatopathy has seen an increase in malaria endemic areas, particularly in Southeast Asia and India. Liver compromise in people with malaria correlates with a greater likelihood of complications and death.

Diagnosis


further2| Diagnosis of malaria The mainstay of malaria diagnosis has been the microscopic examination of blood using blood film s. Although blood is the sample most frequently used to make a diagnosis, both saliva and urine have been investigated as alternative, less invasive specimens. More recently, modern techniques using ELISA|antigen tests or polymerase chain reaction have been discovered, though these are not widely implemented in malaria-endemic regions. Areas that cannot afford laboratory diagnostic tests often use only a history of subjective fever as the indication to treat for malaria.

Prevention




Methods used to prevent the spread of disease, or to protect individuals in areas where malaria is endemic, include prophylactic drugs, mosquito eradication and the prevention of mosquito bites. The continued existence of malaria in an area requires a combination of high human population density, high mosquito population density and high rates of transmission from humans to mosquitoes and from mosquitoes to humans. If any of these is lowered sufficiently, the parasite will eventually disappear from that area, as happened in North America , Europe and much of the Middle East . However, unless the parasite is eliminated from the whole world, it could become re-established if conditions revert to a combination that favours the parasite's reproduction. Many countries are seeing an increasing number of imported malaria cases owing to extensive travel and migration.

Many researchers argue that prevention of malaria may be more cost-effective than treatment of the disease in the long run, but the capital cost s required are out of reach of many of the world's poorest people. The economist Jeffrey Sachs estimates that malaria can be controlled for US$3 billion in aid per year.

A 2008 study that examined international financing of malaria control found large regional variations in the levels of average annual per capita funding ranging from US$0.01 in Myanmar to US$147 in Suriname. The study found 34 countries where the funding was less than US$1 per capita, including 16 countries where annual malaria support was less than US$0.5. The 16 countries included 710 million people or 50% of the global population exposed to the risks of malaria transmission, including seven of the poorest countries in Africa (Côte d'Ivoire, Republic of the Congo, Chad, Mali, Democratic Republic of the Congo, Somalia, and Guinea) and two of the most densely populated stable endemic countries in the world (Indonesia and India).

Brazil , Eritrea , India , and Vietnam , unlike many other developing nations, have successfully reduced the malaria burden. Common success factors have included conducive country conditions, a targeted technical approach using a package of effective tools, data-driven decision-making, active leadership at all levels of government, involvement of communities, decentralised implementation and control of finances, skilled technical and managerial capacity at national and sub-national levels, hands-on technical and programmatic support from partner agencies, and sufficient and flexible financing.

Medications


Main|Malaria prophylaxisSeveral drugs, most of which are used for treatment of malaria, can be taken preventively. Chloroquine may be used where the parasite is still sensitive. However, due to resistance one of three medications, mefloquine ( Lariam ), doxycycline (available generically), and the combination of atovaquone and proguanil hydrochloride ( Malarone ) is frequently needed. Doxycycline and the atovaquone and proguanil combination are the best tolerated; mefloquine is associated with higher rates of neurological and psychiatric symptoms.

The prophylactic effect does not begin immediately upon starting the drugs, so people temporarily visiting malaria-endemic areas usually begin taking the drugs one to two weeks before arriving and must continue taking them for four weeks after leaving (with the exception of atovaquone proguanil that only needs to be started two days prior and continued for 7 days afterwards). Generally, these drugs are taken daily or weekly, at a lower dose than is used for treatment of a person who had contracted the disease. Use of prophylactic drugs is seldom practical for full-time residents of malaria-endemic areas, and their use is usually restricted to short-term visitors and travelers to malarial regions. This is due to the cost of purchasing the drugs, negative adverse effect (medicine)|side effect s from long-term use, and because some effective anti-malarial drugs are difficult to obtain outside of wealthy nations.

Quinine was used historically; however, the development of more effective alternatives such as quinacrine , chloroquine, and primaquine in the 20th century reduced its use. Today, quinine is not generally used for prophylaxis. The use of prophylactic drugs where malaria-bearing mosquitoes are present may encourage the development of partial immunity.

Vector control


further2| Mosquito control
Efforts to Eradication of infectious diseases|eradicate malaria by eliminating mosquitoes have been successful in some areas. Malaria was once common in the United States and southern Europe, but vector control programs, in conjunction with the monitoring and treatment of infected humans, eliminated it from those regions. In some areas, the draining of wetland breeding grounds and better sanitation were adequate. Malaria was eliminated from most parts of the USA in the early 20th century by such methods, and the use of the pesticide DDT and other means eliminated it from the remaining pockets in the South by 1951. (see National Malaria Eradication Program ) In 2002, there were 1,059 cases of malaria reported in the US, including eight deaths, but in only five of those cases was the disease contracted in the United States.

Before DDT, malaria was successfully eradicated or controlled also in several tropical areas by removing or poisoning the breeding grounds of the mosquitoes or the aquatic habitats of the larva stages, for example by filling or applying diesel oil to places with standing water. Another technique was to replace the fresh water in the breeding grounds with salt water. http://www.malariasite.com/malaria/history_control.htm Replacing of sweetwater with salt water for vector control These methods have seen little application in Africa for more than half a century.

Sterile insect technique is emerging as a potential mosquito control method. Progress towards transgenic, or genetically modified organism|genetically modified , insects suggest that wild mosquito populations could be made malaria-resistant. Researchers at Imperial College London created the world's first transgenic malaria mosquito,Imperial College, London, " http://web.archive.org/web/20010509111155/ http://www.ic.ac.uk/templates/text_3.asp? P=1911 Scientists create first transgenic malaria mosquito", 2000-06-22. with the first Plasmodium -resistant species announced by a team at Case Western Reserve University in Ohio in 2002. Successful replacement of current populations with a new genetically modified population, relies upon a drive mechanism, such as transposable elements to allow for non-Mendelian inheritance of the gene of interest. However, this approach contains many difficulties and success is a distant prospect.

Another way to reduce the malaria transmitted to humans from mosquitoes has been developed by the University of Arizona. They have engineered a mosquito to become resistant to malaria. This was reported on 16 July 2010 in the journal PLoS Pathogens . With the ultimate end being that the release of this genetically modified mosquito into the environment, Gareth Lycett, a malaria researcher from Liverpool School of Tropical Medicine told the BBC that "It is another step on the journey towards potentially assisting malaria control through GM mosquito release."

Indoor residual spraying


further2| Indoor residual spraying | DDT#Use_against_malaria|DDT and malaria Indoor residual spraying (IRS) is the practice of spraying insecticides on the interior walls of homes in malaria-affected areas. After feeding, many mosquito species rest on a nearby surface while digesting the bloodmeal, so if the walls of dwellings have been coated with insecticides, the resting mosquitos will be killed before they can bite another victim and transfer the malaria parasite.

The first pesticide used for IRS was DDT . Although it was initially used exclusively to combat malaria, its use quickly spread to agriculture . In time, pest control, rather than disease control, came to dominate DDT use, and this large-scale agricultural use led to the evolution of pesticide resistance|resistant mosquitoes in many regions. The DDT resistance shown by Anopheles mosquitoes can be compared to antibiotic resistance shown by bacteria. The overuse of antibacterial soap s and antibiotics led to antibiotic resistance in bacteria, similar to how overspraying of DDT on crops led to DDT resistance in Anopheles mosquitoes. During the 1960s, awareness of the negative consequences of its indiscriminate use increased, ultimately leading to bans on agricultural applications of DDT in many countries in the 1970s. Since the use of DDT has been limited or banned for agricultural use for some time, DDT may now be more effective as a method of disease-control.

Although DDT has never been banned for use in malaria control and there are several other insecticides suitable for IRS, some advocates have claimed that bans are responsible for tens of millions of deaths in tropical countries where DDT had once been effective in controlling malaria. Furthermore, most of the problems associated with DDT use stem specifically from its industrial-scale application in agriculture, rather than its use in public health .

The World Health Organization (WHO) currently advises the use of 12 insecticides in IRS operations, including DDT as well as alternative insecticides (such as the pyrethroids permethrin and deltamethrin ). http://whqlibdoc.who.int/hq/2006/WHO_HTM_MAL_2006.1112_eng.pdf Indoor Residual Spraying: Use of Indoor Residual Spraying for Scaling Up Global Malaria Control and Elimination. World Health Organization, 2006. This public health use of small amounts of DDT is permitted under the Stockholm Convention on Persistent Organic Pollutant s (POPs), which prohibits the agricultural use of DDT. However, because of its legacy, many developed countries previously discouraged DDT use even in small quantities.

One problem with all forms of Indoor Residual Spraying is insecticide resistance via evolution of mosquitos. According to a study published on Mosquito Behavior and Vector Control, mosquito species that are affected by IRS are endophilic species (species that tend to rest and live indoors), and due to the irritation caused by spraying, their evolutionary descendants are trending towards becoming exophilic (species that tend to rest and live out of doors), meaning that they are not as affected—if affected at all—by the IRS, rendering it somewhat useless as a defense mechanism.

Mosquito nets and bedclothes


Main|Mosquito netMosquito nets help keep mosquitoes away from people and greatly reduce the infection and transmission of malaria. The nets are not a perfect barrier and they are often treated with an insecticide designed to kill the mosquito before it has time to search for a way past the net. Insecticide-treated nets (ITNs) are estimated to be twice as effective as untreated nets and offer greater than 70% protection compared with no net. Although ITNs are proven to be very effective against malaria, only 13% of households in sub-Saharan countries own them. Since the Anopheles mosquitoes feed at night, the preferred method is to hang a large "bed net" above the center of a bed such that it drapes down and covers the bed completely.

Immunization


Main|Malaria vaccineImmunity (or, more accurately, tolerance) does occur naturally, but only in response to repeated infection with multiple strains of malaria. A completely effective Vaccination|vaccine is not yet available for malaria, although several vaccines are under development. SPf66 was tested extensively in endemic areas in the 1990s, but clinical trials showed it to be insufficiently effective. Other vaccine candidates, targeting the blood-stage of the parasite's life cycle, have also been insufficient on their own. Several potential vaccines targeting the pre-erythrocytic stage are being developed, with RTS,S showing the most promising results so far.

Other methods


Education in recognizing the symptoms of malaria has reduced the number of cases in some areas of the developing world by as much as 20%. Recognizing the disease in the early stages can also stop the disease from becoming a killer. Education can also inform people to cover over areas of stagnant, still water e.g. Water Tanks which are ideal breeding grounds for the parasite and mosquito, thus cutting down the risk of the transmission between people. This is most put in practice in urban areas where there are large centers of population in a confined space and transmission would be most likely in these areas.

Other interventions for the control of malaria include mass drug administration s and intermittent preventive therapy .

Furthering attempts to reduce transmission rates, a proposed alternative to mosquito nets is the mosquito laser , or photonic fence, which identifies female mosquitoes and shoots them using a medium-powered laser . http://www.physics.org/featuredetail.asp? id=48 Laser pest control physics.org, May 2010 The device is currently undergoing commercial development, although instructions for a do it yourself|DIY version of the photonic fence have also been published.

Treatment


Further|Antimalarial medicationWhen properly treated, people with malaria can expect a complete recovery. The treatment depends on the severity of the disease; whether people can take oral drugs or must be admitted depends on the assessment and the experience of the clinician. Uncomplicated malaria is treated with oral drugs. The most effective strategy for P.& nbsp;falciparum infection recommended by WHO is the use of artemisinin s in combination with other antimalarials artemisinin-combination therapy (ACT) to avoid the development of drug resistance against artemisinin-based therapies. Recent reports from Southeast Asia suggest evidence of emerging resistance to artemisins.

Severe malaria requires the parenteral administration of antimalarial drugs. Until the mid-2000s the most used treatment for severe malaria was quinine, but artesunate has been shown to be superior to quinine in both children and adults. Treatment of severe malaria also involves supportive measures. Infection with P.& nbsp;vivax , P.& nbsp;ovale or P.& nbsp;malariae is usually treated on an outpatient basis (while a person is at home). Treatment of P.& nbsp;vivax requires both treatment of blood stages (with chloroquine or ACT) as well as clearance of liver forms with primaquine .

Prognosis


legend|#b3b3b3| no data legend|#ffff65| <10 legend|#fff200| 10–100 legend|#ffdc00| 100–500 legend|#ffc600| 500–1000 legend|#ffb000| 1000–1500 legend|#ff9a00| 1500–2000 Multicol-breaklegend|#ff8400| 2000–2500 legend|#ff6e00| 2500–2750 legend|#ff5800| 2750–3000 legend|#ff4200| 3000–3250 legend|#ff2c00| 3250–3500 legend|#cb0000| =3500 Multicol-end Severe malaria can progress extremely rapidly and cause death within hours or days. In the most severe cases of the disease, fatality rate s can exceed 20%, even with intensive care and treatment. In endemic areas, treatment is often less satisfactory and the overall fatality rate for all cases of malaria can be as high as 10%. Over the longer term, developmental impairments have been documented in children who have suffered episodes of severe malaria. It causes widespread anemia during a period of rapid brain development and also direct brain damage. This neurologic damage results from cerebral malaria to which children are more vulnerable.

Epidemiology



Malaria has been a widely prevalent disease throughout human history – some scientists believe that one in every two people who have ever lived has died of it. The WHO has estimated that malaria annually causes 250 million cases of fever; the organization estimated that 655,000 people died from the disease in 2010. However, a 2012 meta-analysis published in The Lancet suggests that deaths are significantly higher, with 1,238,000 people dying from malaria in 2010. The majority of cases occur in children under 5 years old; pregnant women are also especially vulnerable. Despite efforts to reduce transmission and increase treatment, there has been little change in which areas are at risk of this disease since 1992. Indeed, if the prevalence of malaria stays on its present upwards course, the death rate could double in the next twenty years. Precise statistics are unknown because many cases occur in rural areas where people do not have access to hospitals or the means to afford health care. As a consequence, the majority of cases are undocumented.

Although coinfection with HIV and malaria does increase mortality, this is less of a problem than with HIV/ tuberculosis coinfection, due to the two diseases usually attacking different age ranges, with malaria being most common in the young and active tuberculosis most common in the old. Although HIV/malaria coinfection produces less severe symptoms than the interaction between HIV and TB, HIV and malaria do contribute to each other's spread. This effect comes from malaria increasing viral load and HIV infection increasing a person's susceptibility to malaria infection.

Malaria is presently endemic in a broad band around the equator, in areas of the Americas, many parts of Asia, and much of Africa; however, it is in sub-Saharan Africa where 85–90% of malaria fatalities occur. The geographic distribution of malaria within large regions is complex, and malaria-afflicted and malaria-free areas are often found close to each other. Malaria is prevalent in tropical regions because of the significant amounts of rainfall, consistent high temperatures and high humidity, along with stagnant waters in which mosquito larvae readily mature, providing them with the environment they need for continuous breeding. In drier areas, outbreaks of malaria have been predicted with reasonable accuracy by mapping rainfall. Malaria is more common in rural areas than in cities; this is in contrast to dengue fever where urban areas present the greater risk. For example, several cities in Vietnam , Laos and Cambodia are essentially malaria-free, but the disease is present in many rural regions. By contrast, in Africa malaria is present in both rural and urban areas, though the risk is lower in the larger cities. The global Endemic (epidemiology)|endemic levels of malaria have not been mapped since the 1960s. However, the Wellcome Trust , UK, has funded the Malaria Atlas Project to rectify this, providing a more contemporary and robust means with which to assess current and future malaria disease burden . As of 2010, countries with the highest death rate per 100,000 population are Cote d'Ivoire with (86.15), Angola (56.93) and Burkina Faso (50.66) – all in Africa. A map of Plasmodium falciparum endemicity in 2010 has been published.

History


Main|History of malaria
Malaria has infected humans for over 50,000 years, and Plasmodium may have been a human pathogen for the entire history of the species. Close relatives of the human malaria parasites remain common in chimpanzees. Some new evidence suggests that the most virulent strain of human malaria may have originated in gorillas.

References to the unique periodic fevers of malaria are found throughout recorded history, beginning in 2700 BC in China. Malaria may have contributed to the decline of the Roman Empire ,Cite web |title=DNA clues to malaria in ancient Rome |date=February 20, 2001 |work=BBC News |url= http://news.bbc.co.uk/2/hi/science/nature/1180469.stm and was so pervasive in Rome that it was known as the " Roman Fever (disease)|Roman fever ". A number of regions in ancient Rome were considered at-risk for the disease because of the favorable conditions present for malaria vectors. This included areas such as southern Italy, the island of Sardinia , the Pontine Marshes , the lower regions of coastal Etruria and the city of Rome along the Tiber River . The presence of stagnant water in these places was preferred by mosquitoes for breeding grounds. Irrigated gardens, swamp-like grounds, runoff from agriculture, and drainage problems from road construction led to the increase of standing water.

The term malaria originates from Middle Ages|Medieval lang-it|mala aria& nbsp;— " miasma theory of disease|bad air "; the disease was formerly called ague or marsh fever due to its association with swamps and marshland. Malaria was once common in most of Europe and North America, where it is no longer Endemic (epidemiology)|endemic , though imported cases do occur.
Malaria was the most important health hazard encountered by U.S. troops in the South Pacific during World War II , where about 500,000 men were infected. According to Joseph Patrick Byrne, "Sixty thousand American soldiers died of malaria during the African and South Pacific campaigns."
Scientific studies on malaria made their first significant advance in 1880, when a French army doctor working in the military hospital of Constantine, Algeria|Constantine in Algeria named Charles Louis Alphonse Laveran observed parasites for the first time, inside the red blood cells of people suffering from malaria. He therefore proposed that malaria is caused by this organism, the first time a protist was identified as causing disease. For this and later discoveries, he was awarded the 1907 Nobel Prize for Physiology or Medicine . The malarial parasite was called Plasmodium by the Italian scientists Ettore Marchiafava and Angelo Celli . A year later, Carlos Finlay , a Cuban doctor treating people with yellow fever in Havana , provided strong evidence that mosquitoes were transmitting disease to and from humans. This work followed earlier suggestions by Josiah C. Nott , and work by Sir Patrick Manson , the "father of tropical medicine", on the transmission of filariasis .

In April 1894, a Scottish physician Ronald Ross|Sir Ronald Ross visited Sir Patrick Manson at his house on Queen Anne Street, London. This visit was the start of four years of collaboration and fervent research that culminated in 1898 when Ross, who was working in the Presidency General Hospital in Kolkata|Calcutta , proved the complete life-cycle of the malaria parasite in mosquitoes. He thus proved that the mosquito was the vector for malaria in humans by showing that certain mosquito species transmit malaria to birds. He isolated malaria parasites from the salivary glands of mosquitoes that had fed on infected birds. For this work, Ross received the 1902 Nobel Prize in Medicine. After resigning from the Indian Medical Service, Ross worked at the newly established Liverpool School of Tropical Medicine and directed malaria-control efforts in Egypt , Panama , Greece and Mauritius . The findings of Finlay and Ross were later confirmed by a medical board headed by Walter Reed in 1900. Its recommendations were implemented by William C. Gorgas in Health measures during the construction of the Panama Canal|the health measures undertaken during construction of the Panama Canal . This public-health work saved the lives of thousands of workers and helped develop the methods used in future public-health campaigns against the disease.

The first effective treatment for malaria came from the bark of Cinchona|cinchona tree , which contains quinine . This tree grows on the slopes of the Andes , mainly in Peru . The indigenous peoples of Peru made a tincture of cinchona to control malaria. The Jesuit s noted the efficacy of the practice and introduced the treatment to Europe during the 1640s, where it was rapidly accepted. It was not until 1820 that the active ingredient, quinine, was extracted from the bark, isolated and named by the French chemists Pierre Joseph Pelletier and Joseph Bienaimé Caventou . In the 20th century, chloroquine replaced quinine as the treatment of both uncomplicated and severe falciparum malaria until resistance supervened. Artemisinins , discovered by Chinese scientists in the 1970s, are now the recommended treatment for falciparum malaria, administered in combination with other antimalarials as well as in severe disease.

Society and culture


Malaria is not just a disease commonly associated with poverty but also a cause of poverty and a major hindrance to economic development . Tropical regions are affected most; however, malaria’s furthest extent reaches into some temperate zones with extreme seasonal changes. The disease has been associated with major negative economic effects on regions where it is widespread. During the late 19th and early 20th centuries, it was a major factor in the slow economic development of the American southern states. A comparison of average per capita GDP in 1995, adjusted for purchasing power parity|parity of purchasing power , between countries with malaria and countries without malaria gives a fivefold difference ($1,526 USD versus $8,268 USD). In countries where malaria is common, average per capita GDP has risen (between 1965 and 1990) only 0.4% per year, compared to 2.4% per year in other countries.

Poverty is both a cause and effect of malaria, since the poor do not have the financial capacities to prevent or treat the disease. In its entirety, the economic impact of malaria has been estimated to cost Africa $12 billion USD every year. The economic impact includes costs of health care, working days lost due to sickness, days lost in education, decreased productivity due to brain damage from cerebral malaria, and loss of investment and tourism. In some countries with a heavy malaria burden, the disease may account for as much as 40% of public health expenditure, 30–50% of admissions to hospital, and up to 50% of outpatient visits. The slow demographic transition in Africa may be partly attributed to malaria. Total fertility rates were best explained by child mortality , as measured indirectly by infant mortality , in a 2007 study.

A study on the effect of malaria on IQ in a sample of Mexicans found that exposure during the birth year to malaria eradication was associated with increases in IQ. It also increased the probability of employment in a skilled occupation. The author suggests that this may be one explanation for the Flynn effect and that this may be an important explanation for the link between national malaria burden and economic development. The cognitive abilities and school performance are impaired in sub-groups of people (with either cerebral malaria or uncomplicated malaria) when compared with healthy scientific control|controls . Studies comparing cognitive functions before and after treatment for acute malarial illness continued to show significantly impaired school performance and cognitive abilities even after recovery. Malaria prophylaxis was shown to improve cognitive function and school performance in clinical trials when compared to placebo groups. April 25 is World Malaria Day .

Counterfeit and substandard drugs


Sophisticated counterfeit drugs|counterfeits have been found in several Asian countries such as Cambodia , People's Republic of China|China , Indonesia , Laos , Thailand , and Vietnam , and are an important cause of avoidable death in those countries.
The WHO said that studies indicate that up to 40% of artesunate based malaria medications are counterfeit, especially in the Greater Mekong region and have established a rapid alert system to enable information about counterfeit drugs to be rapidly reported to the relevant authorities in participating countries. There is no reliable way for doctors or lay people to detect counterfeit drugs without help from a laboratory. Companies are attempting to combat the persistence of counterfeit drugs by using new technology to provide security from source to distribution.

Another clinical and public health concern is the proliferation of substandard antimalarial medicines resulting from inappropriate concentration of ingredients, contamination with other drugs or toxic impurities, poor quality ingredients, poor stability and inadequate packaging. A 2012 study demonstrated that roughly one-third of antimalarial medications in Southeast Asia and Sub-Saharan Africa failed chemical analysis, packaging analysis, or were falsified.

War


Throughout history, the contraction of malaria (via natural outbreaks as well as via infliction of the disease as a biological warfare agent) has played a prominent role in the fortunes of government rulers, nation-states, military personnel, and military actions. "Malaria Site: History of Malaria During Wars" addresses the devastating impact of malaria in numerous well-known conflicts, beginning in June 323 B.C. That site's authors note: "Many great warriors succumbed to malaria after returning from the warfront and advance of armies into continents was prevented by malaria. In many conflicts, more troops were killed by malaria than in combat." The Centers for Disease Control ("CDC") traces the history of malaria and its impacts farther back, to 2700 BCE.

In 1910, Nobel Prize in Medicine -winner Ronald Ross (himself a malaria survivor), published a book titled The Prevention of Malaria that included a chapter titled "The Prevention of Malaria in War." The chapter's author, Colonel C. H. Melville, Professor of Hygiene at Royal Army Medical College in London, addressed the prominent role that malaria has historically played during wars and advised: "A specially selected medical officer should be placed in charge of these operations with executive and disciplinary powers ...."

Significant financial investments have been made to procure existing and create new anti-malarial agents. During World War I and World War II , the supplies of the natural anti-malaria drugs, cinchona bark and quinine, proved to be inadequate to supply military personnel and substantial funding was funneled into research and development of other drugs and vaccines. American military organizations conducting such research initiatives include the Navy Medical Research Center, Walter Reed Army Institute of Research , and the U.S. Army Medical Research Institute of Infectious Diseases of the US Armed Forces.

Additionally, initiatives have been founded such as Malaria Control in War Areas (MCWA), established in 1942, and its successor, the Communicable Disease Center (now known as the Centers for Disease Control) established in 1946. According to the CDC, MCWA "was established to control malaria around military training bases in the southern United States and its territories, where malaria was still problematic" and, during these activities, to "train state and local health department officials in malaria control techniques and strategies." The CDC's Malaria Division continued that mission, successfully reducing malaria in the United States, after which the organization expanded its focus to include "prevention, surveillance, and technical support both domestically and internationally."

Eradication efforts


Several notable attempts are being made to eliminate the parasite from sections of the world, or to eradicate it worldwide. In 2006, the organization Malaria No More set a public goal of eliminating malaria from Africa by 2015, and the organization plans to dissolve if that goal is accomplished. Several malaria vaccine s are in clinical trials, which are intended to provide protection for children in endemic areas and reduce the speed of transmission of the disease. As of 2012, The Global Fund to Fight AIDS, Tuberculosis and Malaria has distributed 230 million insecticide-treated nets intended to stop mosquito-born transmission of malaria. According to director Inder Singh (philanthropist)|Inder Singh , the U.S.-based Clinton Foundation has significantly reduced the cost of drugs to treat malaria, and is working to further reduce the spread of the disease. Other efforts, such as the Malaria Atlas Project focus on analyzing climate and weather information required to accurately predict the spread of malaria based on the availability of habitat of malaria-carrying parasites.

Malaria has been successfully eradicated in certain areas. The Republic of Mauritius , a tropical island located in the western Indian Ocean, considered ecological connections to malaria transmission when constructing their current plan for malaria control. To prevent mosquitoes from breeding in aquatic areas, DDT is used in moderate amounts. Additionally, larvae-eating fish are placed in water sources to remove the malaria vectors before they become a threat to the human population. Obstructions are also removed from these sources to maintain water flow and reduce stagnant water. Similarly, marsh or swamp-like environments are drained and filled to diminish mosquito breeding grounds. These actions have produced positive results. The program has cut infection and death rates tremendously, and is cost effective, only requiring $1USD per head each year. This success is a clear indication that responses to adverse environmental conditions can decrease rates of disease.

Research


With the onset of drug-resistant Plasmodium parasites, new strategies are required to combat the widespread disease. One such approach lies in the introduction of synthetic pyridoxal -amino acid adducts, which are channeled into the parasite. Thus, trapped upon phosphorylation by plasmodial PdxK (pyridoxine/ pyridoxal kinase ), the proliferation of Plasmodium parasites is effectively hindered by a novel compound, PT3, a cyclic pyridoxyl- tryptophan methyl ester , without harming human cells.

Malaria parasites contain apicoplast s, an organelle usually found in plants, complete with their own functioning genome s. These apicoplasts are thought to have originated through the Endosymbiont|endosymbiosis of algae and play a crucial role in various aspects of parasite metabolism, for example in fatty acid biosynthesis . As of 2003, 466 proteins have been found to be produced by apicoplasts and these are now being investigated as possible targets for novel anti-malarial drugs.

Malaria vaccines have been an elusive goal of research. The first promising studies demonstrating the potential for a malaria vaccine were performed in 1967 by immunizing mice with live, radiation- Attenuator (genetics)|attenuated sporozoites, which provided significant protection to the mice upon subsequent injection with normal, viable sporozoites. Since the 1970s, there has been a considerable effort to develop similar vaccination strategies within humans. It was determined that an individual can be protected from a P.& nbsp;falciparum infection if they receive over 1,000 bites from infected yet irradiated mosquitoes.

References


Reflist|colwidth=30em|refs=
Cite journal |author=Abba K, Deeks JJ, Olliaro P, Naing CM, Jackson SM, Takwoingi Y, Donegan S, Garner P |title=Rapid diagnostic tests for diagnosing uncomplicated P. falciparum malaria in endemic countries |journal=Cochrane Database of Systematic Reviews |year=2011 |issue=7 |pages=CD008122 |pmid=21735422 |doi=10.1002/14651858.CD008122.pub2

Cite journal |author=Abeku TA |title=Response to malaria epidemics in Africa |journal=Emerging Infectious Diseases |year=2007 |volume=14 |issue=5 |pages=681–6 |pmid=17553244 |pmc=2738452 |url= http://wwwnc.cdc.gov/eid/article/13/5/06-1333.htm

Cite journal |author=Achan J, Talisuna AO, Erhart A, Yeka A, Tibenderana JK, Baliraine FN, Rosenthal PJ, D'Alessandro U |title=Quinine, an old anti-malarial drug in a modern world: role in the treatment of malaria |journal=Malaria Journal |year=2011 |volume=10 |page=144 |pmid=21609473 |pmc=3121651 |url= http://www.malariajournal.com/content/10/1/144 |issue=1

Cite journal |author=Adams S, Brown H, Turner G |title=Breaking down the blood-brain barrier: signaling a path to cerebral malaria? |journal=Trends in Parasitology |volume=18 |issue=8 |pages=360–6 |year=2002 |pmid=12377286 |doi=10.1016/S1471-4922(02)02353-X

Cite book |author=Arrow KJ, Panosian C, Gelband H, Institute of Medicine (U.S.). Committee on the Economics of Antimalarial Drugs |title=Saving Lives, Buying Time: Economics of Malaria Drugs in an Age of Resistance |year=2004 |publisher=National Academies Press |isbn=978-0-309-09218-0 |page=141 |url= http://books.google.com/books? id=PL8EmnGt71sC& pg=PA141

Cite web |url= http://www.cdc.gov/malaria/history/index.htm#mcwa |title=History & #124; CDC Malaria |publisher=Cdc.gov |date=February 8, 2010 |accessdate=2012-05-15

Cite journal |author=Barat L |title=Four malaria success stories: how malaria burden was successfully reduced in Brazil, Eritrea, India, and Vietnam |journal=American Journal of Tropical Medicine and Hygiene |volume=74 |issue=1 |pages=12–6 |year=2006 |pmid=16407339

Cite journal |author=Barnabas RV, Webb EL, Weiss HA, Wasserheit JN |title=The role of coinfections in HIV epidemic trajectory and positive prevention: a systematic review and meta-analysis |journal=AIDS |year=2011 |volume=25 |issue=13 |pages=1559–73 |pmid=21633287 |pmc=3151007 |doi=10.1097/QAD.0b013e3283491e3e

Cite book |author=Barnes E |title=Diseases and Human Evolution |edition=1st |publisher=University of New Mexico Press |location=Albuquerque, New Mexico |year=2005 |isbn=978-0-8263-3065-9

Cite journal |author=Beare NA, Taylor TE, Harding SP, Lewallen S, Molyneux ME |title=Malarial retinopathy: a newly established diagnostic sign in severe malaria |journal=American Journal of Tropical Medicine and Hygiene |year=2006 |volume=75 |issue=5 |pages=790–7 |pmid=17123967 |pmc=2367432 |url= http://www.ajtmh.org/cgi/pmidlookup? view=long& pmid=17123967

Cite journal |author=Beare NA, Lewallen S, Taylor TE, Molyneux ME |title=Redefining cerebral malaria by including malaria retinopathy |journal=Future Microbiology |year=2011 |volume=6 |issue=3 |pages=349–55 |pmid=21449844 |doi=10.2217/fmb.11.3

Cite journal |author=Bhalla A, Suri V, Singh V |title=Malarial hepatopathy |journal=Journal of Postgraduate Medicine |volume=52 |issue=4 |pages=315–20 |year=2006 |pmid=17102560 |url= http://www.jpgmonline.com/article.asp? issn=0022-3859;year=2006;volume=52;issue=4;spage=315;epage=320;aulast=Bhalla

Cite journal |author=Bledsoe GH |title=Malaria primer for clinicians in the United States |journal=Southern Medical Journal |volume=98 |issue=12 |pages=1197–204; quiz 1205, 1230 |year=2005 |pmid=16440920 |url= http://journals.lww.com/smajournalonline/Fulltext/2005/12000/Malaria_Primer_for_Clinicians_in_the_United_States.12.aspx |doi=10.1097/01.smj.0000189904.50838.eb

Cite book |author=Bray RS |title=Armies of Pestilence: The Effects of Pandemics on History |year=2004 |publisher=James Clarke |isbn=978-0-227-17240-7 |page=102 |url= http://books.google.com/books? id=djPWGnvBm08C& pg=PA102

Cite journal |author=Breman J |title=The ears of the hippopotamus: manifestations, determinants, and estimates of the malaria burden |journal=American Journal of Tropical Medicine and Hygiene |year=2001 |volume=64 |issue=1–2 Suppl |pages=1–11 |pmid=11425172

Cite book |author=Byrne JP |title=Encyclopedia of Pestilence, Pandemics, and Plagues: A-M |year=2008 |publisher=ABC-CLIO |isbn=978-0-313-34102-1 |page=383 |url= http://books.google.com/books? id=5Pvi-ksuKFIC& pg=PA383

cite journal |author=Caudron J-M, Ford N, Henkens M, Macé, Kidle-Monroe R, Pinel J |title=Substandard medicines in resource-poor settings: a problem that can no longer be ignored |journal=Tropical Medicine & International Health |year=2008 |volume=13 |issue=8 |pages=1062–72 |pmid=18631318 |doi=10.1111/j.1365-3156.2008.02106.x

Cite web |title=Eradication of Malaria in the United States (1947–1951) |url= http://www.cdc.gov/malaria/about/history/elimination_us.html |publisher=US Centers for Disease Control and Prevention |date=February 8, 2010 |accessdate=2012-05-02

Cite web |title=Malaria |url= http://www.dpd.cdc.gov/dpdx/HTML/ImageLibrary/Malaria_il.htm |publisher= US Centers for Disease Control and Prevention |date=April 15, 2010 |accessdate=2012-05-02

Cite web |url= http://www.cdc.gov/malaria/about/faqs.html#treatment |title=Frequently Asked Questions (FAQs): If I get malaria, will I have it for the rest of my life? |publisher=US Centers for Disease Control and Prevention |date=February 8, 2010 |accessdate=2012-05-14

Cite web |title=Ross and the Discovery that Mosquitoes Transmit Malaria Parasites |work=CDC Malaria website |url= http://www.cdc.gov/malaria/history/ross.htm |accessdate=2012-06-14 |archiveurl= http://web.archive.org/web/20070602185153/ http://www.cdc.gov/malaria/history/ross.htm |archivedate=2007-06-02

Cite journal |author=Chen Q, Schlichtherle M, Wahlgren M |title=Molecular aspects of severe malaria |journal=Clinical Microbiology Reviews |volume=13 |issue=3 |pages=439–50 |year=2000 |pmid=10885986 |pmc=88942 |doi=10.1128/CMR.13.3.439-450.2000 |url= http://cmr.asm.org/cgi/pmidlookup? view=long& pmid=10885986

Cite journal |author=Chernin E |title=Patrick Manson (1844–1922) and the transmission of filariasis |journal=American Journal of Tropical Medicine and Hygiene |volume=26 |issue=5 Pt 2 Suppl |pages=1065–70 |year=1977 |pmid=20786 |url= http://www.ajtmh.org/cgi/pmidlookup? view=long& pmid=20786

Cite journal |author=Chernin E |title=Josiah Clark Nott, insects, and yellow fever |journal=Bulletin of the New York Academy of Medicine |volume=59 |issue=9 |pages=790–802 |year=1983 |pmid=6140039 |pmc=1911699

Cite journal |author=Collins WE, Barnwell JW |title= Plasmodium knowlesi: finally being recognized |journal=Journal of Infectious Diseases |year=2009 |volume=199 |issue=8 |pages=1107–8 |doi=10.1086/597415 |pmid=19284287

Cite journal |author=Collins WE |title= Plasmodium knowlesi : a malaria parasite of monkeys and humans |journal=Annual Review of Entomology |year=2012 |volume=57 |pages=107–21 |pmid=22149265 |doi=10.1146/annurev-ento-121510-133540

Cite report |author=Conley D, McCord GC, Sachs JD |title=Africa's Lagging Demographic Transition: Evidence from Exogenous Impacts of Malaria Ecology and Agricultural Technology |date=February 2007 |work=NBER Working Paper No. 12892 |publisher=National Bureau of Economic Research |url= http://www.nber.org/papers/w12892

Cite journal |author=Corby-Harris V, Drexler A, Watkins de Jong L, Antonova Y, Pakpour N, Ziegler R, Ramberg F, Lewis EE, Brown JM, Luckhart S, Riehle MA |year=2010 |title=Activation of Akt signaling reduces the prevalence and intensity of malaria parasite infection and lifespan in Anopheles stephensi mosquitoes |journal=PLoS Pathogens |pmid=20664791 |volume=6 |issue=7 |pmc=2904800 |page=e1001003 |doi=10.1371/journal.ppat.1001003

Cite journal |author=Cox F |title=History of human parasitology |pmc=126866 |journal=Clinical Microbiology Reviews |volume=15 |issue=4 |pages=595–612 |year=2002 |pmid=12364371 |doi=10.1128/CMR.15.4.595-612.2002

Cite journal |author=Dondorp AM, Day NP |title=The treatment of severe malaria |journal=Transactions of the Royal Society of Tropical Medicine and Hygiene |volume=101 |issue=7 |pages=633–4 |year=2007 |pmid=17434195 |doi=10.1016/j.trstmh.2007.03.011

Cite journal |author=Dondorp AM, Fanello CI, Hendriksen IC, Gomes E, Seni A, Chhaganlal KD, Bojang K, Olaosebikan R, Anunobi N, Maitland K, Kivaya E, Agbenyega T, Nguah SB, Evans J, Gesase S, Kahabuka C, Mtove G, Nadjm B, Deen J, Mwanga-Amumpaire J, Nansumba M, Karema C, Umulisa N, Uwimana A, Mokuolu OA, Adedoyin OT, Johnson WB, Tshefu AK, Onyamboko MA, Sakulthaew T, Ngum WP, Silamut K, Stepniewska K, Woodrow CJ, Bethell D, Wills B, Oneko M, Peto TE, von Seidlein L, Day NP, White NJ; AQUAMAT group |title=Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial |journal=Lancet |volume=376 |issue=9753 |pages=1647–57 |year=2010 |pmid=21062666 |doi=10.1016/S0140-6736(10)61924-1 |pmc=3033534

Cite journal |author=Enayati A, Hemingway J |title=Malaria management: past, present, and future |journal=Annual Review of Entomology |year=2010 |volume=55 |pages=569–91 |pmid=19754246 |doi=10.1146/annurev-ento-112408-085423

Cite journal |author=Escalante A, Ayala F |title=Phylogeny of the malarial genus Plasmodium , derived from rRNA gene sequences |journal=Proceedings of the National Academy of Sciences USA |volume=91 |issue=24 |pages=11373–7 |year=1994 |pmid=7972067 |pmc=45233 |doi=10.1073/pnas.91.24.11373

Cite journal |author=Färnert A, Williams TN, Mwangi TW, Ehlin A, Fegan G, Macharia A, Lowe BS, Montgomery SM, Marsh K |title=Transmission-dependent tolerance to multiclonal Plasmodium falciparum infection |journal=Journal of Infectious Diseases |year=2009 |volume=200 |issue=7 |pages=1166–75 |doi=10.1086/605652 |pmid=19702508

Cite book |author=Fernando RL, Fernando SSE, Siew-Yin Leong A |title=Tropical Infectious Diseases: Epidemiology, Investigation, Diagnosis and Management |year=2001 |publisher=Cambridge University Press |isbn=978-1-900151-39-9 |page=26 |url= http://books.google.com/books? id=H_HMXkI5BC4C& pg=PA26

Cite journal |author=Fernando SD, Rodrigo C, Rajapakse S |title=The 'hidden' burden of malaria: cognitive impairment following infection |journal=Malaria Journal |volume=9 |page=366 |year=2010 |pmid=21171998 |pmc=3018393 |doi=10.1186/1475-2875-9-366 |url= http://www.malariajournal.com/content/9//366

Cite web |author=Finkel M |title=Malaria |url= http://ngm.nationalgeographic.com/ngm/0707/feature1/text3.html |work=July 2007 issue |publisher=National Geographic |accessdate=2011-12-30

Cite journal |author=Foth BJ, Ralph SA, Tonkin CJ, Struck NS, Fraunholz M, Roos DS, Cowman AF, McFadden GI |year=2003 |title=Dissecting apicoplast targeting in the malaria parasite Plasmodium falciparum |journal=Science |volume=299 |issue=5607 |pages=705–8 |url= http://www.sciencemag.org/cgi/content/abstract/299/5607/705 |doi=10.1126/science.1078599 |pmid=12560551

Cite journal |author=Freedman DO |title=Clinical practice. Malaria prevention in short-term travelers |journal=New England Journal of Medicine |year=2008 |volume=359 |issue=6 |pages=603–12 |pmid=18687641 |url= http://www.nejm.org/doi/full/10.1056/NEJMcp0803572 |doi=10.1056/NEJMcp0803572

Cite journal |author=Gautam CS, Utreja A, Singal GL |title=Spurious and counterfeit drugs: a growing industry in the developing world |journal=Postgraduate Medical Journal |year=2009 |volume=85 |pages=251–6 |pmid=19520877 |doi=10.1136/pgmj.2008.073213

Cite journal |author=Geels MJ, Imoukhuede EB, Imbault N, van Schooten H, McWade T, Troye-Blomberg M, Dobbelaer R, Craig AG, Leroy O |title=European Vaccine Initiative: lessons from developing malaria vaccines |journal=Expert Review of Vaccines |year=2011 |volume=10 |issue=12 |pages=1697–708 |pmid=22085173 |url= http://www.euvaccine.eu/sites/default/files/uploads/docs/Pubs_and_articles/2011_Expert_Reviews_Vaccines_vol._10_-_12.pdf |format=PDF

Cite journal |author=Gething PW, Patil AP, Smith DL, Guerra CA, Elyazar IR, Johnston GL, Tatem AJ, Hay SI |title=A new world malaria map: Plasmodium falciparum endemicity in 2010 |journal=Malaria Journal |volume=10 |issue=1 |page=378 |year=2011 |pmid=22185615 |doi=10.1186/1475-2875-10-378 |url= http://www.malariajournal.com/content/10/1/378 |pmc=3274487

Cite news |author=Gill V |url= http://www.bbc.co.uk/news/science-environment-10654599 |title=Malaria-proof mosquito engineered |date=July 16, 2010 |newspaper= BBC News Online |accessdate=2012-05-02

Cite web |title=Fighting AIDS, Tuberculosis and Malaria |url= http://www.theglobalfund.org/en/about/diseases/ |publisher=The Global Fund |accessdate=2012-05-09

Cite book |author=Gratz NG, World Health Organization |title=The Vector- and Rodent-borne Diseases of Europe and North America: Their Distribution and Public Health Burden |url= http://books.google.com/books? id=UXEe2aZXA88C |year=2006 |publisher=Cambridge University Press |isbn=978-0-521-85447-4

Cite journal |author=Graves P, Gelband H |title=Vaccines for preventing malaria (SPf66) |issue=2 |pages=CD005966 |journal=Cochrane Database of Systematic Reviews (online) |year=2006 |pmid=16625647 |editor1-last=Graves PM |doi=10.1002/14651858.CD005966

Cite journal |author=Graves P, Gelband H |title=Vaccines for preventing malaria (blood-stage) |issue=4 |pages=CD006199 |journal=Cochrane Database of Systematic Reviews (online) |year=2006 |editor1-last=Graves PM |pmid=17054281 |doi=10.1002/14651858.CD006199

Cite journal |author=Greenwood B, Mutabingwa T |title=Malaria in 2002 |journal=Nature |year=2002 |volume=415 |issue=6872 |pages=670–2 |pmid=11832954 |doi=10.1038/415670a

Cite journal |author=Greenwood BM, Bojang K, Whitty CJ, Targett GA |title=Malaria |journal=Lancet |year=2005 |volume=365 |issue=9469 |pages=1487–98 |pmid=15850634 |doi=10.1016/S0140-6736(05)66420-3

Cite journal |author=Grobusch MP, Egan A, Gosling RD, Newman RD |title=Intermittent preventive therapy for malaria: progress and future directions |journal=Current Opinion in Infectious Diseases |year=2007 |volume=20 |issue=6 |pages=613–20 |pmid=17975412 |url= http://www.ipti-malaria.org/LinkClick.aspx? fileticket=Buwx9cIn2tA%3D& tabid=228 |format=PDF

Cite journal |author=Guerra CA, Hay SI, Lucioparedes LS, Gikandi PW, Tatem AJ, Noor AM, Snow RW |title=Assembling a global database of malaria parasite prevalence for the Malaria Atlas Project |journal=Malaria Journal |year=2007 |issue=6 |page=17 |pmid=17306022 |pmc=1805762 |doi=10.1186/1475-2875-6-17

Cite journal |author=Hartman TK, Rogerson SJ, Fischer PR |title=The impact of maternal malaria on newborns |journal=Annals of Tropical Paediatrics |year=2010 |volume=30 |issue=4 |pages=271–82 |pmid=21118620 |doi=10.1179/146532810X12858955921032

Cite journal |author=Hay S, Guerra C, Tatem A, Noor A, Snow R |title=The global distribution and population at risk of malaria: past, present, and future |journal=Lancet Infectious Diseases |volume=4 |issue=6 |pages=327–36 |year=2004 |pmid=15172341 |pmc=3145123 |doi=10.1016/S1473-3099(04)01043-6

Cite book |author=Hays JN |title=Epidemics and Pandemics: Their Impacts on Human History |publisher=ABC-CLIO |year=2005

Cite journal |author=Hill AVS |title=Vaccines against malaria |journal=Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences |year=2011 |volume=366 |issue=1579 |pages=2806–14 |pmid=21893544 |pmc=3146776 |doi=10.1098/rstb.2011.0091

Cite journal |author=Hsu E |title=Reflections on the ‘discovery’ of the antimalarial qinghao |journal=British Journal of Clinical Pharmacology |year=2006 |volume=61 |issue=3 |pages=666–70 |pmid=16722826 |pmc=1885105 |doi=10.1111/j.1365-2125.2006.02673.x

Cite book |author=Humphreys M |title=Malaria: Poverty, Race, and Public Health in the United States |publisher=Johns Hopkins University Press |year=2001 |page=256 |isbn=0-8018-6637-5

Cite journal |author=Idro R, Otieno G, White S, Kahindi A, Fegan G, Ogutu B, Mithwani S, Maitland K, Neville BG, Newton CR |title=Decorticate, decerebrate and opisthotonic posturing and seizures in Kenyan children with cerebral malaria |journal=Malaria Journal |volume=4 |page=57 |year=2005 |pmc=1326205 |pmid=16336645 |doi=10.1186/1475-2875-4-57

Cite web |url= http://ftp.iza.org/dp2997.pdf |format=PDF |title=Malaria: Disease Impacts and Long-Run Income Differences |publisher= Institute for the Study of Labor

Cite web |publisher=Imperial College of Science, Technology and Medicine, London |url= http://web.archive.org/web/20010509111155/ http://www.ic.ac.uk/templates/text_3.asp? P=1911 |title=Scientists create first transgenic malaria mosquito |date=June 22, 2000

Cite journal |author=Ito J, Ghosh A, Moreira LA, Wimmer EA, Jacobs-Lorena M |title=Transgenic anopheline mosquitoes impaired in transmission of a malaria parasite |journal=Nature |year=2002 |volume=417 |issue=6887 |pages=452–5 |pmid=12024215 |doi=10.1038/417452a

Cite journal |author=Jacquerioz FA, Croft AM |title=Drugs for preventing malaria in travellers |journal=Cochrane Database of Systematic Reviews |issue=4 |pages=CD006491 |year=2009 |pmid=19821371 |doi=10.1002/14651858.CD006491.pub2 |editor1-last=Jacquerioz FA

Cite journal |author=Jansen CC, Beebe NW |title=The dengue vector Aedes aegypti : what comes next |journal=Microbes and Infection |year=2010 |volume=12 |issue=4 |pages=272–9 |pmid=20096802 |doi=10.1016/j.micinf.2009.12.011

Cite journal |author=Joy DA, Feng X, Mu J, Furuya T, Chotivanich K, Krettli AU, Ho M, Wang A, White NJ, Suh E, Beerli P, Su XZ |title=Early origin and recent expansion of Plasmodium falciparum |journal=Science |volume=300 |issue=5617 |pages=318–21 |year=2003 |pmid=12690197 |doi=10.1126/science.1081449

Cite web |author=Olver C |url= http://journalistsresource.org/studies/government/international/global-malaria-mortality-1980-2010-systematic-analysis/ |title=Global Malaria Mortality Between 1980 and 2010: A Systematic Analysis |publisher=journalistsresource.org |date=February 28, 2012 |accessdate=2012-05-03

Cite journal |author=Kain K, Harrington M, Tennyson S, Keystone J |title=Imported malaria: prospective analysis of problems in diagnosis and management |journal=Clinical Infectious Diseases |volume=27 |issue=1 |pages=142–9 |year=1998 |pmid=9675468 |doi=10.1086/514616

Cite journal |author=Kare J |title=Backyard Star Wars: build your own photonic fence to zap mosquitoes midflight |date=May 2010 |journal=IEEE Spectrum |url= http://spectrum.ieee.org/consumer-electronics/gadgets/backyard-star-wars |accessdate=2012-05-03

Cite journal |author=Kaufman T, Rúveda E |title=The quest for quinine: those who won the battles and those who won the war |journal=Angewandte Chemie (International Edition in English) |volume=44 |issue=6 |pages=854–85 |year=2005 |pmid=15669029 |doi=10.1002/anie.200400663

Cite journal |author=Killeen G, Fillinger U, Kiche I, Gouagna L, Knols B |title=Eradication of Anopheles gambiae from Brazil: lessons for malaria control in Africa? |journal=Lancet Infectious Diseases |volume=2 |issue=10 |pages=618–27 |year=2002 |pmid=12383612 |doi=10.1016/S1473-3099(02)00397-3

Cite journal |author=Knols BG, Bossin HC, Mukabana WR, Robinson AS |title=Transgenic mosquitoes and the fight against malaria: managing technology push in a turbulent GMO world |journal=American Journal of Tropical Medicine and Hygiene |volume=77 |issue=6 Suppl |pages=232–42 |year=2007 |pmid=18165498 |url= http://www.ajtmh.org/content/77/6_Suppl/232.full? sid=b4961cce-7150-41b5-9f6f-f74a2358ae2d

Cite journal |author=Kokwaro G |title=Ongoing challenges in the management of malaria |journal=Malaria Journal |year=2009 |volume=8 |issue=Suppl 1 |page=S2 |pmid=19818169 |pmc=2760237 |doi=10.1186/1475-2875-8-S1-S2

Cite journal |author=Korenromp E, Williams B, de Vlas S, Gouws E, Gilks C, Ghys P, Nahlen B |title=Malaria attributable to the HIV-1 epidemic, sub-Saharan Africa |url= http://www.cdc.gov/ncidod/EID/vol11no09/05-0337.htm |journal=Emerging Infectious Diseases |volume=11 |issue=9 |pages=1410–9 |year=2005 |pmid=16229771 |pmc=3310631 |doi=10.3201/eid1109.050337

Cite journal |author=Kwiatkowski DP |title=How malaria has affected the human genome and what human genetics can teach us about malaria |journal=American Journal of Human Genetics |volume=77 |issue=2 |pages=171–92 |year=2005 |pmid=16001361 |pmc=1224522 |doi=10.1086/432519

Cite journal |author=Kyle R, Shampe M |title=Discoverers of quinine |journal=Journal of the American Medical Association |volume=229 |issue=4 |page=462 |year=1974 |pmid=4600403 |doi=10.1001/jama.229.4.462

Cite journal |author=Murray CJ, Rosenfeld LC, Lim SS, Andrews KG, Foreman KJ, Haring D, Fullman N, Naghavi M, Lozano R, Lopez AD |title=Global malaria mortality between 1980 and 2010: a systematic analysis" |journal=Lancet |volume=379 |issue=9814 |pages=413–31 |year=2012 |pmid=22305225 |doi=10.1016/S0140-6736(12)60034-8

Cite web |title=The Nobel Prize in Physiology or Medicine 1907: Alphonse Laveran |publisher=The Nobel Foundation |url= http://nobelprize.org/nobel_prizes/medicine/laureates/1907/laveran-bio.html |accessdate=2012-05-14

Cite web |author=Layne SP |title=Principles of Infectious Disease Epidemiology |work=EPI 220 |publisher=UCLA Department of Epidemiology |url= http://www.ph.ucla.edu/epi/layne/Epidemiology+220/07.malaria.pdf |archiveurl= http://web.archive.org/web/20060220083223/ http://www.ph.ucla.edu/epi/layne/Epidemiology+220/07.malaria.pdf |archivedate=2006-02-20 |accessdate=2007-06-15 |format=PDF

Cite journal |author=Lim L, McFadden GI |title=The evolution, metabolism and functions of the apicoplast |journal=Philosophical Transactions of the Royal Society B: Biological Sciences |year=2010 |volume=365 |issue=1541 |pages=749–63 |pmid=20124342 |pmc=2817234 |doi=10.1098/rstb.2009.0273

Cite book |author=Lindemann M |title=Medicine and Society in Early Modern Europe |year=1999 |publisher=Cambridge University Press |isbn=978-0-521-42354-0 |page=62 |url= http://books.google.com/books? id=fQxAkrbksTEC& pg=PA62

Cite journal |author=Lon CT |title=Counterfeit and substandard antimalarial drugs in Cambodia |year=2006 |journal=Transactions of the Royal Society of Tropical Medicine and Hygiene |volume=100 |issue=11 |pages=1019–24 |pmid=16765399 |doi=10.1016/j.trstmh.2006.01.003

Cite journal|author=Machault V, Vignolles C, Borchi F, Vounatsou P, Pages F, Briolant S, Lacaux JP, Rogier C |title=The use of remotely sensed environmental data in the study of malaria |journal=Geospatial Health |year=2011 |volume=5 |issue=2 |pages=151–68 |pmid=21590665 |url= http://www.geospatialhealth.unina.it/articles/v5i2/gh-v5i2-1-machault.pdf |format=PDF

Cite journal |author=Maier AG, Cooke BM, Cowman AF, Tilley L |title=Malaria parasite proteins that remodel the host erythrocyte |journal=Nature Reviews Microbiology |year=2009 |volume=7 |issue=5 |pages=341–54 |pmid=19369950 |doi=10.1038/nrmicro2110

Cite web |title=History of Malaria During Wars |url= http://www.malariasite.com/malaria/history_wars.htm |author=Kakkilaya BS |publisher= http://www.malariasite.com |date=April 14, 2006 |accessdate=2012-05-03

Cite journal |author=malERA Consultative Group on Drugs |title=A research agenda for malaria eradication: drugs |journal=PloS Medicine |year=2011 |volume=8 |issue=1 |page=e1000402 |pmid=21311580 |pmc=3026688

Cite journal |author=Maltha J, Jacobs J |title=The diagnosis of imported malaria in children |journal=European Journal of Pediatrics |year=2011 |volume=170 |issue=7 |pages=821–9 |pmid=21499691 |pmc=3117262

Cite web |url= http://www.medicalnewstoday.com/articles/74907.php |title=Medical News Today |date=June 24, 2007 |publisher=Medicalnewstoday.com |accessdate=2010-08-24

Cite journal |author=Mendis K, Sina B, Marchesini P, Carter R |title=The neglected burden of Plasmodium vivax malaria |journal=American Journal of Tropical Medicine and Hygiene |volume=64 |issue=1–2 Suppl |pages=97–106 |year=2001 |pmid=11425182 |url= http://www.ajtmh.org/cgi/reprint/64/1_suppl/97.pdf |format=PDF

Cite journal |author=Miller JM, Korenromp EL, Nahlen BL, W Steketee R |title=Estimating the number of insecticide-treated nets required by African households to reach continent-wide malaria coverage targets |journal=Journal of the American Medical Association |year=2007 |volume=297 |issue=20 |pages=2241–50 |pmid=17519414 |doi=10.1001/jama.297.20.2241

Cite journal |author=Mockenhaupt F, Ehrhardt S, Burkhardt J, Bosomtwe S, Laryea S, Anemana S, Otchwemah R, Cramer J, Dietz E, Gellert S, Bienzle U |title=Manifestation and outcome of severe malaria in children in northern Ghana |journal=American Journal of Tropical Medicine and Hygiene |volume=71 |issue=2 |pages=167–72 |year=2004 |pmid=15306705

Cite journal |author=Mueller I, Zimmerman PA, Reeder JC |title= Plasmodium malariae and Plasmodium ovale —the "bashful" malaria parasites |journal=Trends in Parasitology |volume=23 |issue=6 |pages=278–83 |year=2007 |pmid=17459775 |doi=10.1016/j.pt.2007.04.009

Cite journal |author=Müller IB, Wu F, Bergmann B, Knöckel J, Walter RD, Gehring H, Wrenger C |title=Poisoning pyridoxal 5-phosphate-dependent enzymes: a new strategy to target the malaria parasite Plasmodium falciparum |journal=PLoS ONE |volume=4 |issue=2 |pages=e4406 |year=2009 |pmid=19197387 |pmc=2634962 |doi=10.1371/journal.pone.0004406

cite journal |author=Nayyar GML, Breman JG, Newton PN, Herrington J |title=Poor-quality antimalarial drugs in southeast Asia and sub-Saharan Africa |journal=Lancet Infectious Diseases |year=2012 |volume=12 |issue=6 |pages=488–96 |doi=10.1016/S1473-3099(12)70064-6

Cite journal |author=Newton PN Green MD, Fernández FM, Day NPJ, White NJ |title=Counterfeit anti-infective drugs |journal=Lancet Infectious Diseases |year=2006 |volume=6 |issue=9 |pages=602–13 |pmid=16931411 |doi=10.1016/S1473-3099(06)70581-3

Cite journal |author=Newton PN, Fernández FM, Plançon A, Mildenhall DC, Green MD, Ziyong L, Christophel EM, Phanouvong S, Howells S, McIntosh E, Laurin P, Blum N, Hampton CY, Faure K, Nyadong L, Soong CW, Santoso B, Zhiguang W, Newton J, Palmer K |title=A collaborative epidemiological investigation into the criminal fake artesunate trade in South East Asia |journal=PLoS Medicine |year=2008 |volume=5 |issue=2 |page=e32 |pmid=18271620 |pmc=2235893 |doi=10.1371/journal.pmed.0050032

Cite journal |author=Owusu-Ofori AK, Parry C, Bates I |title=Transfusion-transmitted malaria in countries where malaria is endemic: a review of the literature from sub-Saharan Africa |journal=Clinical Infectious Diseases |year=2010 |volume=51 |issue=10 |pages=1192–8 |pmid=20929356 |doi=10.1086/656806

Cite journal |author=Parry J |title=WHO combats counterfeit malaria drugs in Asia |journal=British Medical Journal |year=2005 |volume=330 |issue=7499 |page=1044 |pmid=15879383 |url= http://www.bmj.com/cgi/content/full/330/7499/1044-d

Cite journal |author=Pates H, Curtis C |title=Mosquito behaviour and vector control |journal=Annual Review of Entomology |volume=50 |pages=53–70 |year=2005 |pmid=15355233 |doi=10.1146/annurev.ento.50.071803.130439

Cite journal |author=Pelletier PJ, Caventou JB |title=Des recherches chimiques sur les Quinquinas |trans_title=Chemical research on quinquinas |language=French |journal=Annales de Chimie et de Physique |volume=15 |pages=337–65 |year=1820 |url= http://books.google.com/books? id=veE3AAAAMAAJ& pg=PA337

Cite journal |author=Perkins MD, Bell DR |title=Working without a blindfold: the critical role of diagnostics in malaria control |journal=Malaria Journal |year=2008 |volume=1 |issue=Suppl 1 |page=S5 |pmid=19091039 |pmc=2604880 |doi=10.1186/1475-2875-7-S1-S5

Cite journal |author=Phyo AP, Nkhoma S, Stepniewska K, Ashley EA, Nair S, McGready R, Ler Moo C, Al-Saai S, Dondorp AM, Lwin KM, Singhasivanon P, Day NP, White NJ, Anderson TJ, Nosten F |title=Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study |journal=Lancet |year=2012 |doi=10.1016/S0140-6736(12)60484-X |url= http://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2812%2960484-X/abstract

Cite news |author=Provost C |url= http://www.guardian.co.uk/global-development/datablog/2011/apr/25/world-malaria-day-data#data |work=The Guardian |title=World Malaria Day: which countries are the hardest hit? Get the full data |date=April 25, 2011 |accessdate=2012-05-03

Cite journal |author=Prothero RM |title=Malaria, forests and people in Southeast Asia |journal=Singapore Journal of Tropical Geography |volume=20 |issue=1 |pages=76–85 |year=1999 |doi=10.1111/1467-9493.00044

Cite journal |author=Prugnolle F, Durand P, Ollomo B, Duval L, Ariey F, Arnathau C, Gonzalez JP, Leroy E, Renaud F |title=A fresh look at the origin of Plasmodium falciparum , the most malignant malaria agent |journal=PLoS Pathogens |year=2011 |volume=7 |issue=2 |page=e1001283 |pmid=21383971 |pmc=3044689 |doi=10.1371/journal.ppat.1001283

Cite journal |author=Raghavendra K, Barik TK, Reddy BP, Sharma P, Dash AP |title=Malaria vector control: from past to future |journal=Parasitology Research |year=2011 |volume=108 |issue=4 |pages=757–79 |pmid=21229263 |doi=10.1007/s00436-010-2232-0

Cite journal |author=Reiter P |title=From Shakespeare to Defoe: malaria in England in the Little Ice Age |journal=Emerging Infectious Diseases |volume=6 |issue=1 |pages=1–11 |year=2000 |pmid=10653562 |pmc=2627969 |url= http://www.cdc.gov/ncidod/EID/vol6no1/reiter.htm

Cite journal |author=Richter J, Franken G, Mehlhorn H, Labisch A, Häussinger D |title=What is the evidence for the existence of Plasmodium ovale hypnozoites? |journal=Parasitology Research |year=2010 |volume=107 |issue=6 |pages=1285–90 |pmid=20922429 |doi=10.1007/s00436-010-2071-z

Cite journal |author=Rijken MJ, McGready R, Boel ME, Poespoprodjo R, Singh N, Syafruddin D, Rogerson S, Nosten F |title=Malaria in pregnancy in the Asia-Pacific region |journal=Lancet Infectious Diseases |year=2012 |volume=12 |issue=1 |pages=75–88 |pmid=22192132 |doi=10.1016/S1473-3099(11)70315-2

Cite book |author=Roberts JL |chapter=Malaria Control in Mauritius |title=Africa Environment Outlook: Human Vulnerability to Environmental Change |publisher=Earthprint Limited |location=United Kingdom |year=2004 |pages=161–8 |isbn=978-92-807-2365-6

Cite web |author=Roll Back Malaria WHO partnership |title=Economic costs of malaria |url= http://www.rollbackmalaria.org/cmc_upload/0/000/015/363/RBMInfosheet_10.pdf |format=PDF |publisher= World Health Organization|WHO

Cite news |author=Rosenberg T |title=What the world needs now is DDT |publisher=New York Times |date=April 11, 2004 |url= http://www.nytimes.com/2004/04/11/magazine/what-the-world-needs-now-is-ddt.html |accessdate=2012-05-03

Cite web |title=The Nobel Prize in Physiology or Medicine 1902: Ronald Ross |publisher=The Nobel Foundation |url= http://nobelprize.org/nobel_prizes/medicine/laureates/1902/ross-bio.html |accessdate=2012-05-14

Cite journal |author=Sachs J, Malaney P |title=The economic and social burden of malaria |journal=Nature |year=2002 |volume=415 |issue=6872 |pages=680–5 |pmid=11832956 |doi=10.1038/415680a

Cite book |author=Sallares R |title=Malaria and Rome: A History of Malaria in Ancient Italy |year=2002 |publisher=Oxford University Press |isbn=978-0-19-924850-6 |doi=10.1093/acprof:oso/9780199248506.001.0001

Cite journal |author=Sarkar PK, Ahluwalia G, Vijayan VK, Talwar A |title=Critical care aspects of malaria |journal=Journal of Intensive Care Medicine |year=2009 |volume=25 |issue=2 |pages=93–103 |pmid=20018606 |doi=10.1177/0885066609356052

Cite book |author=Schlagenhauf-Lawlor P |title=Travelers' Malaria |year=2008 |publisher=PMPH-USA |isbn=978-1-55009-336-0 |page=215 |url= http://books.google.com/books? id=54Dza0UHyngC& pg=PA215

Cite book |author=Simmons JS |title=Malaria in Panama |year=1979 |publisher=Ayer Publishing |isbn=978-0-405-10628-6 |url= http://books.google.com/books? id=arMN_3pqxDcC& pg=PP1

Cite journal |author=Snow RW, Guerra CA, Noor AM, Myint HY, Hay SI |title=The global distribution of clinical episodes of Plasmodium falciparum malaria |journal=Nature |volume=434 |issue=7030 |pages=214–7 |year=2005 |pmid=15759000 |doi=10.1038/nature03342 |pmc=3128492

Cite journal |author=Snow RW, Guerra CA, Mutheu JJ, Hay SI |title=International funding for malaria control in relation to populations at risk of stable Plasmodium falciparum transmission |journal=PLoS Medicine |year=2008 |pmid=18651785 |pages=e142 |volume=5 |issue=7 |pmc=2488181 |doi=10.1371/journal.pmed.0050142 |editor1-last=Krishna S

Cite news |author=Strom S |author-link=Stephanie Strom |date=April 1, 2011 |title=Mission Accomplished, Nonprofits Go Out of Business |newspaper=The New York Times |at=nytimes.com |url= http://www.nytimes.com/2011/04/02/business/02charity.html |oclc=292231852 |accessdate=2012-05-09

Cite journal |author=Sutherland CJ, Hallett R |title=Detecting malaria parasites outside the blood |journal=Journal of Infectious Diseases |year=2009 |volume=199 |issue=11 |pages=1561–3 |doi=10.1086/598857 |pmid=19432543

Cite journal |author=Talman A, Domarle O, McKenzie F, Ariey F, Robert V |title=Gametocytogenesis: the puberty of Plasmodium falciparum |journal=Malaria Journal |volume=3 |page=24 |year=2004 |pmid=15253774 |pmc=497046 |doi=10.1186/1475-2875-3-24

Cite journal |author=Tan SY, Sung H |title=Carlos Juan Finlay (1833–1915): of mosquitoes and yellow fever |journal=Singapore Medical Journal |volume=49 |issue=5 |pages=370–1 |year=2008 |pmid=18465043 |url= http://smj.sma.org.sg/4905/4905ms1.pdf |format=PDF

Cite journal |author=Tia E, Akogbeto M, Koffi A, Toure M, Adja AM, Moussa K, Yao T, Carnevale P, Chandre E |title=Pyrethroid and DDT resistance of Anopheles gambiae s.s. (Diptera: Culicidae) in five agricultural ecosystems from Côte-d'Ivoire |language=French |journal=Bulletin de la Société de pathologie exotique (1990) |volume=99 |issue=4 |pages=278–82 |year=2006 |pmid=17111979

Cite journal |author=Trampuz A, Jereb M, Muzlovic I, Prabhu R |title=Clinical review: severe malaria |pmc=270697 |journal=Critical Care |volume=7 |issue=4 |pages=315–23 |year=2003 |pmid=12930555 |doi=10.1186/cc2183

Cite journal |author=Trung H, Van Bortel W, Sochantha T, Keokenchanh K, Quang N, Cong L, Coosemans M |title=Malaria transmission and major malaria vectors in different geographical areas of Southeast Asia |journal=Tropical Medicine & International Health |volume=9 |issue=2 |pages=230–7 |year=2004 |pmid=15040560 |doi=10.1046/j.1365-3156.2003.01179.x

Cite journal |author=Turschner S, Efferth T |title=Drug resistance in Plasmodium : natural products in the fight against malaria |journal=Mini Reviews in Medicinal Chemistry |year=2009 |volume=9 |issue=2 |pages=206–14 |pmid=19200025 |doi=10.2174/138955709787316074

Cite book |author=Valkiunas G |title=Avian Malaria Parasites and Other Haemosporidia |year=2005 |publisher=CRC Press |isbn=978-0-415-30097-1 |page=589 |url= http://books.google.com/books? id=2btzeZON0qgC& pg=PA589

Cite journal |author=van den Berg H |year=2009 |title=Global status of DDT and its alternatives for use in vector control to prevent disease |journal=Environmental Health Perspectives |volume=117 |issue=11 |pages=1656–63 |pmid=20049114 |pmc=2801202 |doi=10.1289/ehp.0900785

Cite journal |author=Vanderberg JP |title=Reflections on early malaria vaccine studies, the first successful human malaria vaccination, and beyond |journal=Vaccine |year=2009 |volume=27 |issue=1 |pages=2–9 |pmid=18973784 |pmc=2637529 |doi=10.1016/j.vaccine.2008.10.028

Cite journal |author=Vaughan AM, Aly AS, Kappe SH |title=Malaria parasite pre-erythrocytic stage infection: gliding and hiding |journal=Cell Host & Microbe |year=2008 |volume=4 |issue=3 |pages=209–18 |pmid=18779047 |pmc=2610487 |doi=10.1016/j.chom.2008.08.010

Cite web |author=Venkataramani A |title=Early life exposure to malaria and cognition and skills in adulthood: evidence from Mexico |date=September 18, 2010 |publisher= Social Science Research Network |url= http://ssrn.com/abstract=1679164

Cite book |author=Waters NC, Edstein MD |editor-last=Staines HM, Krishna S (eds) |chapter=8-Aminoquinolines: primaquine and tafenoquine |title=Treatment and Prevention of Malaria: Antimalarial Drug Chemistry, Action and Use |year=2012 |publisher=Springer |isbn=978-3-0346-0479-6 |pages=69–93 |url= http://books.google.com/books? id=cNuY6tyyyrUC& pg=PA69

Cite book |author=Webb Jr JLA |title=Humanity's Burden: A Global History of Malaria |url= http://books.google.com/books? id=xxF2GwAACAAJ |year=2009 |publisher=Cambridge University Press |isbn=978-0-521-67012-8

Cite web |url= http://www.webmd.com/a-to-z-guides/malaria-symptoms |publisher= WebMD |title=Malaria symptoms |date=April 20, 2011 |accessdate=2012-05-9

Cite journal |author=Wellems TE |title= Plasmodium chloroquine resistance and the search for a replacement antimalarial drug |journal=Science |volume=298 |issue=5591 |pages=124–6 |year=2002 |pmid=12364789 |doi=10.1126/science.1078167

Cite journal |author=White NJ |title=Determinants of relapse periodicity in Plasmodium vivax malaria |journal=Malaria Journal |year=2011 |volume=10 |page=297 |pmid=21989376 |pmc=3228849 |doi=10.1186/1475-2875-10-297

Cite book |author=World Health Organization |chapter=Malaria |title=The First Ten Years of the World Health Organization |year=1958 |url= http://whqlibdoc.who.int/publications/a38153_(ch12).pdf |format=PDF |publisher=World Health Organization |pages=172–87

Cite report |author=World Health Organization |title=World Malaria Report 2008 |year=2008 |url= http://www.who.int/entity/pmnch/topics/add_publications/2008_worldmalariarep/en/ |isbn=978-92-4-156369-7

Cite report |url= http://www.who.int/malaria/world_malaria_report_2011/wmr2011_summary_keypoints.pdf |format=PDF |title=World Malaria Report 2011 summary |publisher=World Health Organization

Cite web |author=Schoofs M |title=Clinton foundation sets up malaria-drug price plan |url= http://online.wsj.com/article/SB121626447476161201.html |date=July 17, 2008 |publisher=Wall Street Journal |accessdate=2012-05-14


Further reading


  • Cite book |author=Packard RM |title=The Making of a Tropical Disease: A Short History of Malaria |url= http://books.google.com/books? id=B_V1Xj6wH7IC |year=2007 |publisher=JHU Press |isbn=978-0-8018-8712-3 |series=Johns Hopkins Biographies of Disease

  • Cite book |author=Shah S |title=The Fever: How Malaria Has Ruled Humankind for 500,000 Years |url= http://books.google.com/books? id=4jUjPh64X9UC |year=2010|publisher=Macmillan |isbn=978-0-374-23001-2 http://www.amazon.com/Fever-Malaria-Ruled-Humankind-Years/dp/0374230013/ excerpt and text search

  • Cite book |author=Bynum WF, Overy C |title=The Beast in the Mosquito: The Correspondence of Ronald Ross and Patrick Manson |url= http://books.google.com/books? id=5BXbsSJLaToC |year=1998 |publisher=Rodopi |isbn=978-90-420-0721-5 |series=Wellcome Institute Series in The History of Medicine


  • External links


    commons category
  • dmoz|Health/Conditions_and_Diseases/Infectious_Diseases/Parasitic/Malaria

  • http://www.who.int/malaria/ WHO site on malaria

  • http://www.unhco.org/malaria/ UNHCO site on malaria

  • http://www.rollbackmalaria.org/gmap/ Global Malaria action Plan

  • http://www.rollbackmalaria.org/wmr2005/ World Malaria Report 2005

  • http://doctorswithoutborders.org/news/issue.cfm? id=2395 Doctors Without Borders/Médecins Sans Frontičres – Malaria information pages

  • http://www.wehi.edu.au/other_domains/MalDB/who.html Who/TDR Malaria Database

  • http://www.antimalariaomd.org/en/index.php Anti malaria and sustainable development

  • http://www.wwarn.org Worldwide Antimalarial Resistance Network (WWARN)


  • Diseases of PovertyChromalveolate diseases
    Category:Apicomplexa
    Category:Insect-borne diseases
    Category:Malaria
    Category:Medical emergencies
    Category:Protozoal diseases
    Category:Tropical diseases
    Category:Deaths from malaria
    Category:Millennium Development Goals

    Link GA|ruLink FA|deLink FA|hiLink FA|uk
    af:Malaria
    ar:?????
    an:Malaria
    ast:Malaria
    gn:Akanundu ro'y
    az:Malyariya
    bn:???????????
    zh-min-nan:Ma-lá-lí-á
    be:???????
    be-x-old:???????
    bg:???????
    bs:Malarija
    br:Malaria
    ca:Malŕria
    cs:Malárie
    cy:Malaria
    da:Malaria
    de:Malaria
    dv:????????
    et:Malaaria
    el:?????s?a
    es:Malaria
    eo:Malario
    eu:Malaria
    fa:???????
    fo:Malaria
    fr:Paludisme
    ga:Maláire
    gl:Malaria
    gu:???????
    ko:????
    hy:???????
    hi:???????
    hr:Malarija
    io:Malario
    id:Malaria
    ia:Malaria
    is:Malaría
    it:Malaria
    he:?????
    jv:Malaria
    kn:???????
    ka:???????
    kk:??????
    sw:Malaria
    ht:Malarya
    ku:Lerzeta
    la:Malaria
    lv:Malarija
    lt:Maliarija
    ln:Malariyá
    hu:Malária
    mk:????????
    ml:???????
    mt:Malarja
    mr:???????
    arz:???????
    ms:Malaria
    my:?????????????
    nl:Malaria
    ne:???
    new:???
    ja:????
    no:Malaria
    nn:Malaria
    oc:Malŕria
    om:Busaa
    pnb:??????
    ps:??????
    pl:Malaria
    pt:Malária
    ro:Malarie
    qu:Chukchu
    rue:???????
    ru:???????
    sa:????????
    scn:Malaria
    si:?????????
    simple:Malaria
    sk:Malária
    sl:Malarija
    so:Malaariyo
    sr:????????
    sh:Malarija
    su:Malaria
    fi:Malaria
    sv:Malaria
    tl:Malarya
    ta:???????
    te:???????
    th:????????
    tr:Sitma
    uk:???????
    ur:??????
    vi:S?t rét
    fiu-vro:Malaaria
    war:Malaryá
    yi:???????
    yo:Mŕláríŕ
    bat-smg:Maliareje
    zh:??

    Copyright Citations

    This article is licensed under the GNU License
    Click here for original article: Malaria





          

     
       
     
    Home  |  About Us  |  Privacy  |  Sitemap  |  FAQs  |  Terms and Conditions
     
    Copyright 2012, iCubator Labs, LLC, All Rights Reserved.